Latus Bio, Inc. raised $54M in Series A financing led by 8VC and DCVC Bio to develop gene therapy candidates for CNS disorders.
Amount Raised
$54 Million
Round Type
Series A
PhiladelphiaBiotechnologyHealth CareInvestors
Description
Latus Bio, Inc. has announced the launch and an initial close of $54 million in Series A financing. The funding round is being led by 8VC and DCVC Bio, with syndicate partners including Samsung Life Science Fund, The Children’s Hospital of Philadelphia Foundation, Benjamin Franklin Technology Partners, Modi Ventures, and Gaingels.
Quick answer
Latus Bio raised $54 Million in a Series A round, dated May 2, 2024. Investors: Gaingels, Modi Ventures, Benjamin Franklin Technology Partners, The Children’s Hospital Of Philadelphia Foundation, Samsung Life Science Fund, DCVC Bio and 8VC. Latus Bio is based in Philadelphia, Pennsylvania, United States.
- How much did Latus Bio raise?
- Latus Bio raised $54 Million in a Series A round on May 2, 2024.
- Who invested in Latus Bio?
- Gaingels, Modi Ventures, Benjamin Franklin Technology Partners, The Children’s Hospital Of Philadelphia Foundation, Samsung Life Science Fund, DCVC Bio and 8VC are named as investors in this round.
- What does Latus Bio do?
- Latus Bio is a post-platform company with proprietary technologies to identify and engineer novel AAV capsid variants with unprecedented potency, specificity, and develop ability, screening directly in non-human..
- Where is Latus Bio based and how big is it?
- Latus Bio is based in Philadelphia, Pennsylvania, United States. Fundz records about 29 employees.
- Who are the decision-makers at Latus Bio?
- Fundz holds 2 contacts at Latus Bio, including the Chief Operating Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Latus Bio that raised within 45 days of this round, from Fundz verified event records.
- Hubly raised $1.3M on June 14, 2024.
- Novabay raised $226K on June 14, 2024.
- UPyTher raised $1.5M (Seed) on June 13, 2024.
- InduPro raised $85M (Series A) on June 13, 2024.
- Sova Health raised $1M (Seed) on June 11, 2024.
- Moleculent AB raised $26M (Series A) on June 11, 2024.
Who to call at Latus Bio, and when
A new round usually means Latus Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Latus Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Latus Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Latus Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Latus Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansLatus Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.